Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Patient Participation 1Multiple Myeloma 1Lymphoma 1Febrile Neutropenia 1

Interventions

Cyclophosphamide 79fludarabine phosphate 75Busulfan 53Whole-Body Irradiation 51Mycophenolic Acid 50Cyclosporine 47Peripheral Blood Stem Cell Transplantation 46fludarabine 42Antilymphocyte Serum 37Melphalan 36Tacrolimus 35Filgrastim 30Cord Blood Stem Cell Transplantation 27Radiotherapy 23Methotrexate 22Cytarabine 22Methylprednisolone 19Granulocyte Colony-Stimulating Factor 18apixaban 17Thiotepa 17Dalteparin 13thymoglobulin 12Rivaroxaban 12Alemtuzumab 12eltrombopag 11ferric carboxymaltose 10Surveys and Questionnaires 10Etoposide 10Epoetin Alfa 10Cyclosporins 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × TKN732 × Classical hematology × Clear all
NCT06116734 2023-11-03

Lapelga vs Gastrofil

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Unknown
74 enrolled
Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Patient Participation, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡